Financial News · Live Terminal

Page 24 of 299

Compass Point Initiates Brookdale Senior Living at Buy With $22 Price Target

Brookdale Senior Living (BKD) has an average rating of buy and mean price target of $19.10, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

Compass Point Initiates Brookdale Senior Living at Buy With $22 Price Target

Macquarie Upgrades Elevra Lithium to Outperform from Neutral; Price Target is AU$14.50

Canaccord Genuity Initiates Twist Bioscience at Buy With $90 Price Target

Roth Capital Initiates Better Home & Finance at Buy With $35 Price Target

Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen

KeyBanc Upgrades Firefly Aerospace to Overweight From Sector Weight, Price Target is $50

JPMorgan Initiates ESCO Technologies at Overweight With $420 Price Target

Goldman Sachs Upgrades Shionogi & Co to Buy from Neutral; Price Target is 3,400 Yen

Tokai Tokyo Downgrades Press Kogyo to Neutral from Outperform; Price Target is 900 Yen

KGI Securities Starts Lincotrade & Associates at Outperform with SG$0.366 Price Target

UBS Initiates Jade Biosciences at Buy With $45 Price Target

KeyBanc Upgrades Rocket Lab to Overweight From Sector Weight, Price Target is $135

Citigroup Downgrades Saia to Neutral From Buy, Adjusts Price Target to $524 From $516

HSBC Initiates Vista Energy at Buy With $95 Price Target

Keefe Bruyette & Woods Initiates Lincoln International at Market Perform With $26 Price Target

Goldman Sachs Initiates Lincoln International at Buy With $27.50 Price Target

BMO Capital Initiates Lincoln International at Market Perform With $26 Price Target

Citigroup Downgrades Old Dominion Freight Line to Sell From Neutral, Adjusts PT to $228 From $225

Citigroup Downgrades C.H. Robinson Worldwide to Neutral From Buy, Price Target is $199

Morgan Stanley Downgrades Accenture to Equalweight From Overweight, Adjusts PT to $177 From $240

Compass Point Initiates Brookdale Senior Living at Buy With $22 Price Target

Macquarie Upgrades Elevra Lithium to Outperform from Neutral; Price Target is AU$14.50

Canaccord Genuity Initiates Twist Bioscience at Buy With $90 Price Target

Roth Capital Initiates Better Home & Finance at Buy With $35 Price Target

Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen

KeyBanc Upgrades Firefly Aerospace to Overweight From Sector Weight, Price Target is $50

JPMorgan Initiates ESCO Technologies at Overweight With $420 Price Target

Goldman Sachs Upgrades Shionogi & Co to Buy from Neutral; Price Target is 3,400 Yen

Tokai Tokyo Downgrades Press Kogyo to Neutral from Outperform; Price Target is 900 Yen

KGI Securities Starts Lincotrade & Associates at Outperform with SG$0.366 Price Target

UBS Initiates Jade Biosciences at Buy With $45 Price Target

KeyBanc Upgrades Rocket Lab to Overweight From Sector Weight, Price Target is $135

Citigroup Downgrades Saia to Neutral From Buy, Adjusts Price Target to $524 From $516

HSBC Initiates Vista Energy at Buy With $95 Price Target

Keefe Bruyette & Woods Initiates Lincoln International at Market Perform With $26 Price Target

Goldman Sachs Initiates Lincoln International at Buy With $27.50 Price Target

BMO Capital Initiates Lincoln International at Market Perform With $26 Price Target

Citigroup Downgrades Old Dominion Freight Line to Sell From Neutral, Adjusts PT to $228 From $225

Citigroup Downgrades C.H. Robinson Worldwide to Neutral From Buy, Price Target is $199

Morgan Stanley Downgrades Accenture to Equalweight From Overweight, Adjusts PT to $177 From $240